{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:55:38Z","timestamp":1793404538292,"version":"4.5.0"},"reference-count":58,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.1001\/jamapsychiatry.2021.2236","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T11:02:30Z","timestamp":1629284550000},"page":"1270","source":"Crossref","is-referenced-by-count":52,"title":["Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease"],"prefix":"10.1001","volume":"78","author":[{"given":"James A.","family":"Blumenthal","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Hinderliter","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana L.","family":"Watkins","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson M.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Kraus","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Davidson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sherwood","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"yoi210050r1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/(ISSN)1522-7154","article-title":"Economic costs of anxiety disorders.","volume":"2","author":"DuPont","year":"1996","journal-title":"Anxiety"},{"issue":"6","key":"yoi210050r2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"yoi210050r3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/da.v37.10","article-title":"US Census Bureau\u2013assessed prevalence of anxiety and depressive symptoms in 2019 and during the 2020 COVID-19 pandemic.","volume":"37","author":"Twenge","year":"2020","journal-title":"Depress Anxiety"},{"issue":"3","key":"yoi210050r4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.genhosppsych.2007.12.006","article-title":"Anxiety disorders and comorbid medical illness.","volume":"30","author":"Roy-Byrne","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"yoi210050r5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/YCO.0000000000000217","article-title":"Anxiety as a risk factor in cardiovascular disease.","volume":"29","author":"Allgulander","year":"2016","journal-title":"Curr Opin Psychiatry"},{"issue":"4","key":"yoi210050r6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.amjcard.2016.05.041","article-title":"Meta-analysis of anxiety as a risk factor for cardiovascular disease.","volume":"118","author":"Emdin","year":"2016","journal-title":"Am J Cardiol"},{"issue":"4","key":"yoi210050r7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0022-3999(00)00170-7","article-title":"Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction.","volume":"49","author":"Lane","year":"2000","journal-title":"J Psychosom Res"},{"issue":"2","key":"yoi210050r8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00006842-200103000-00005","article-title":"Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety.","volume":"63","author":"Lane","year":"2001","journal-title":"Psychosom Med"},{"issue":"12","key":"yoi210050r9","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1177\/1359105312467390","article-title":"Generalized anxiety disorder prevalence and comorbidity with depression in coronary heart disease: a meta-analysis.","volume":"18","author":"Tully","year":"2013","journal-title":"J Health Psychol"},{"key":"yoi210050r10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jad.2016.01.003","article-title":"Is there cardiac risk in panic disorder? an updated systematic review.","volume":"194","author":"Caldirola","year":"2016","journal-title":"J Affect Disord"},{"issue":"1","key":"yoi210050r11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/archgenpsychiatry.2007.4","article-title":"Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease.","volume":"65","author":"Frasure-Smith","year":"2008","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"yoi210050r12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jacc.2010.03.034","article-title":"Anxiety and risk of incident coronary heart disease: a meta-analysis.","volume":"56","author":"Roest","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"yoi210050r13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jacc.2010.03.033","article-title":"Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men.","volume":"56","author":"Janszky","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"yoi210050r14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.annepidem.2014.03.001","article-title":"Trait anxiety and somatic concerns associate with increased mortality risk: a 23-year follow-up in aging men.","volume":"24","author":"Tolmunen","year":"2014","journal-title":"Ann Epidemiol"},{"issue":"6","key":"yoi210050r15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/13548506.2012.749355","article-title":"A review of the affects of worry and generalized anxiety disorder upon cardiovascular health and coronary heart disease.","volume":"18","author":"Tully","year":"2013","journal-title":"Psychol Health Med"},{"issue":"2","key":"yoi210050r16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0002-9149(91)90432-K","article-title":"In-hospital symptoms of psychological stress as predictors of long-term outcome after acute myocardial infarction in men.","volume":"67","author":"Frasure-Smith","year":"1991","journal-title":"Am J Cardiol"},{"issue":"3","key":"yoi210050r17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jpsychores.2007.09.007","article-title":"Anxiety and depression as risk factors for mortality after coronary artery bypass surgery.","volume":"64","author":"Tully","year":"2008","journal-title":"J Psychosom Res"},{"issue":"4","key":"yoi210050r18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10865-008-9153-8","article-title":"The role of depression and anxiety symptoms in hospital readmissions after cardiac surgery.","volume":"31","author":"Tully","year":"2008","journal-title":"J Behav Med"},{"issue":"7","key":"yoi210050r19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/PSY.0b013e31814b8c0f","article-title":"Anxiety predicts mortality and morbidity after coronary artery and valve surgery\u2014a 4-year follow-up study.","volume":"69","author":"Sz\u00e9kely","year":"2007","journal-title":"Psychosom Med"},{"issue":"9","key":"yoi210050r20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/PSY.0b013e3182364992","article-title":"Relationship of persistent symptoms of anxiety to morbidity and mortality outcomes in patients with coronary heart disease.","volume":"73","author":"Moser","year":"2011","journal-title":"Psychosom Med"},{"issue":"2","key":"yoi210050r21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000068","article-title":"Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease.","volume":"2","author":"Watkins","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"yoi210050r22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/PSY.0b013e3181dbff97","article-title":"Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis.","volume":"72","author":"Roest","year":"2010","journal-title":"Psychosom Med"},{"issue":"9","key":"yoi210050r23","article-title":"Exercise for depression.","author":"Cooney","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"yoi210050r24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jacc.2012.04.040","article-title":"Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study.","volume":"60","author":"Blumenthal","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"yoi210050r25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/bjsports-2012-091287","article-title":"Exercise for anxiety disorders: systematic review.","volume":"48","author":"Jayakody","year":"2014","journal-title":"Br J Sports Med"},{"key":"yoi210050r26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ahj.2016.03.003","article-title":"Treatment of anxiety in patients with coronary heart disease: rationale and design of the Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) randomized clinical trial.","volume":"176","author":"Blumenthal","year":"2016","journal-title":"Am Heart J"},{"issue":"6","key":"yoi210050r27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/acp.1983.67.issue-6","article-title":"The Hospital Anxiety and Depression Scale.","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"yoi210050r29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2466\/pr0.1965.16.2.633","article-title":"Predictive and concurrent validity of the Altus Information Inventory with high school students.","volume":"16","author":"Gorsuch","year":"1965","journal-title":"Psychol Rep"},{"issue":"2","key":"yoi210050r30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1037\/1040-3590.19.2.176","article-title":"Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3.","volume":"19","author":"Taylor","year":"2007","journal-title":"Psychol Assess"},{"issue":"10","key":"yoi210050r31","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"24","key":"yoi210050r32","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1001\/jama.2016.7635","article-title":"Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: The MOOD-HF randomized clinical trial.","volume":"315","author":"Angermann","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"yoi210050r33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0002-9149(88)91298-2","article-title":"Comparison of high- and low-intensity exercise training early after acute myocardial infarction.","volume":"61","author":"Blumenthal","year":"1988","journal-title":"Am J Cardiol"},{"issue":"4","key":"yoi210050r34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/0002-9149(87)90795-8","article-title":"Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.","volume":"59","author":"Kleiger","year":"1987","journal-title":"Am J Cardiol"},{"issue":"3","key":"yoi210050r35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/oxfordjournals.eurheartj.a014868","article-title":"Heart rate variability. standards of measurement, physiological interpretation, and clinical use.","volume":"17","author":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology","year":"1996","journal-title":"Eur Heart J"},{"issue":"6 pt 1","key":"yoi210050r36","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.HYP.13.6.647","article-title":"Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing.","volume":"13","author":"Parati","year":"1989","journal-title":"Hypertension"},{"issue":"2","key":"yoi210050r37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"yoi210050r38","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/0735-1097(94)90141-4","article-title":"Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction.","volume":"24","author":"Celermajer","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"yoi210050r39","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1097\/HCR.0000000000000379","article-title":"Establishing the minimal clinically important difference for the Hospital Anxiety and Depression Scale in patients with cardiovascular disease.","volume":"39","author":"Lemay","year":"2019","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"yoi210050r40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1477-7525-6-46","article-title":"The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease.","volume":"6","author":"Puhan","year":"2008","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"yoi210050r41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1517\/14740338.2013.840583","article-title":"Antidepressant and QT interval prolongation, how should we look at this issue? focus on citalopram.","volume":"13","author":"Pae","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"yoi210050r42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jama.279.4.287","article-title":"Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.","volume":"279","author":"Roose","year":"1998","journal-title":"JAMA"},{"issue":"6","key":"yoi210050r43","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/00006842-200011000-00007","article-title":"Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.","volume":"62","author":"Strik","year":"2000","journal-title":"Psychosom Med"},{"issue":"6","key":"yoi210050r44","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/jama.288.6.701","article-title":"Sertraline treatment of major depression in patients with acute MI or unstable angina.","volume":"288","author":"Glassman","year":"2002","journal-title":"JAMA"},{"issue":"7","key":"yoi210050r45","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/PSY.0b013e31814b260d","article-title":"Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.","volume":"69","author":"Honig","year":"2007","journal-title":"Psychosom Med"},{"issue":"4","key":"yoi210050r46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/jama.297.4.367","article-title":"Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.","volume":"297","author":"Lesp\u00e9rance","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"yoi210050r47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/da.2012.29.issue-6","article-title":"Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.","volume":"29","author":"Thaler","year":"2012","journal-title":"Depress Anxiety"},{"issue":"1","key":"yoi210050r48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jpsychores.2011.07.001","article-title":"Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD).","volume":"72","author":"Hansen","year":"2012","journal-title":"J Psychosom Res"},{"issue":"1","key":"yoi210050r49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4088\/JCP.14m09281","article-title":"Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial.","volume":"76","author":"Kim","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"yoi210050r50","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/jama.2018.9422","article-title":"Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial.","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"yoi210050r51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.9758\/cpn.2017.15.2.126","article-title":"Effects of escitalopram on anxiety in patients with acute coronary syndrome: a randomized controlled trial.","volume":"15","author":"Kang","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"4","key":"yoi210050r52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0022-3999(04)00064-9","article-title":"Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women.","volume":"57","author":"Hughes","year":"2004","journal-title":"J Psychosom Res"},{"issue":"2","key":"yoi210050r53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/PSY.0000000000000144","article-title":"Association of depressive and anxiety symptoms with 24-hour urinary catecholamines in individuals with untreated high blood pressure.","volume":"77","author":"Paine","year":"2015","journal-title":"Psychosom Med"},{"issue":"12","key":"yoi210050r54","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1111\/eci.12553","article-title":"Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications.","volume":"45","author":"Grassi","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"yoi210050r55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jad.2018.12.063","article-title":"Examining a training effect on the state anxiety response to an acute bout of exercise in low and high anxious individuals.","volume":"247","author":"Lucibello","year":"2019","journal-title":"J Affect Disord"},{"issue":"2","key":"yoi210050r56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/da.v38.2","article-title":"The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial.","volume":"38","author":"Blumenthal","year":"2021","journal-title":"Depress Anxiety"},{"issue":"4","key":"yoi210050r57","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.encep.2008.04.004","article-title":"Efficacit\u00e9 et tol\u00e9rance de l'escitalopram dans les troubles anxieux: revue de la litt\u00e9rature [Efficacy and tolerability of escitalopram in anxiety disorders: a review].","volume":"34","author":"Pelissolo","year":"2008","journal-title":"Encephale"},{"issue":"1","key":"yoi210050r58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0193-953X(05)70205-7","article-title":"Comorbidity in generalized anxiety disorder.","volume":"24","author":"Noyes","year":"2001","journal-title":"Psychiatr Clin North Am"},{"key":"yoi210050r28","unstructured":"John M. Eisenberg Center for Clinical Decisions and Communications Science. Comparative effectiveness review summary guides for clinicians. Accessed July 19, 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK99902\/"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2783295\/jamapsychiatry_blumenthal_2021_oi_210050_1635884821.48255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T11:08:14Z","timestamp":1635937694000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2783295"}},"subtitle":["The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.2236","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}